Harbin Medisan Pharmaceutical Co., Ltd. announced at the EGM held on November 25, 2022 that the company approved election of Zhuge Guomin, Liang Yanfei and Zhu Zihong as non-independent directors, Liu Hongquan as independent director and Zhai Yuping and Gao Lu as non-employee supervisors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.28 CNY | -2.28% | +3.63% | -24.69% |
04-26 | Harbin Medisan Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023 | CI |
04-26 | Medisan Pharma's Potassium Chloride Injection Passes Drug Regulator's Evaluation | MT |
1st Jan change | Capi. | |
---|---|---|
-24.69% | 440M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
-2.71% | 159B |
- Stock Market
- Equities
- 002900 Stock
- News Harbin Medisan Pharmaceutical Co., Ltd.
- Harbin Medisan Pharmaceutical Co., Ltd. Approves Management Appointments